GrantRover ↗

← All topics

Topic

Cancer research funding

Calls for cancer research, from prevention and early detection to treatment and survivorship.

50 current calls · United States 42 · European Union 8 · 5 close in the next 30 days

Tips for this field

Current calls, soonest deadline first

National Institutes of Health United States

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

PAR-25-096

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications pro…

Defense Health Agency Contracting Activity - DHACA United States

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

HT942526BCRPBTA122

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make…

Defense Health Agency Contracting Activity - DHACA United States

DoW Breast Cancer, Clinical Research Extension Award

HT942526BCRPCREA2

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up…

Defense Health Agency Contracting Activity - DHACA United States

DoW Rare Cancers Idea Development Award

HT942526RCRPIDA

Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the …

Defense Health Agency Contracting Activity - DHACA United States

DoW Rare Cancers Resource and Community Development Award

HT942526RCRPRCDA

Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Resource and Community Development Award (RCDA) supports the development of research resources a…

National Institutes of Health United States

NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed)

PAR-27-088

This notice of funding opportunity (NOFO) will invite applications for the Research Specialist Award (R50), which provides salary support for exceptional, non-tenure trac…

National Institutes of Health United States

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

PAR-25-079

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation of scientific discoveries and engineering developm…

National Institutes of Health United States

Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)

PAR-25-098

The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICs) are issuing this R01 to solicit applic…

National Institutes of Health United States

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

PAR-25-081

Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initi…

National Institutes of Health United States

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

PAR-26-149

This Notice of Funding Opportunity (NOFO) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-Designated Cancer Centers. CCSGs support three …

National Institutes of Health United States

Innovative Research to Improve Native Hawaiian and Pacific Islander (NHPI) Health Outcomes (R34 - Clinical Trial Optional)

RFA-MD-27-004

The National Institute on Minority Health and Health Disparities (NIMHD), intends to publish a Notice of Funding Opportunity (NOFO) for planning grants to support prepara…

National Institutes of Health United States

Partnership with Common Fund Data Ecosystem Resources

RFA-RM-28-009

The NIH Office of Strategic Coordination (Common Fund) has generated many valuable and widely available datasets. The Common Fund Data Ecosystem is helping to ensure that…

National Institutes of Health United States

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

RFA-CA-28-002

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing exploratory research projects focused on furt…

National Institutes of Health United States

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

RFA-CA-28-001

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies for cancer…

Horizon Europe European Union

Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers

HORIZON-MISS-2027-02-CANCER-02

Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes: • Patients affl…

Horizon Europe European Union

Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research

HORIZON-MISS-2027-02-CANCER-04

Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes: • People at ris…

Horizon Europe European Union

Leveraging functional genomics to reveal novel targets for cancer treatment

HORIZON-MISS-2027-02-CANCER-01

Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes: • Researchers an…

Horizon Europe European Union

Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes

HORIZON-MISS-2027-02-CANCER-03

Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes: • Patients with…

Horizon Europe European Union

Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines

HORIZON-MISS-2027-02-CANCER-05

This action supports the follow-up to the July 2023 Communication on EU Missions assessment [1] . Proposals under this topic should aim to deliver results that are direct…

Horizon Europe European Union

Living labs to monitor and mitigate carcinogenic substances in and originating from soils: Evaluating their effects on human cancer risks

HORIZON-MISS-2027-06-SOIL-CANCER

Activities under this topic will directly progress towards the goal of the Mission Soil to set up 100 living labs and lighthouses to lead the transition to healthy soils …

National Institutes of Health United States

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

PAR-25-104

The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cance…

National Institutes of Health United States

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

PAR-25-244

This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/geneti…

National Institutes of Health United States

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)

PAR-25-338

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate efforts to translate scientific discoveries and engineering de…

National Institutes of Health United States

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)

PAR-25-337

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate efforts to translate scientific discoveries and engineering de…

National Institutes of Health United States

Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)

PAR-25-243

This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/geneti…

National Institutes of Health United States

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

PAR-25-145

The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative research projects designed to address adverse sequelae of cancer therapies that per…

National Institutes of Health United States

Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)

PAR-25-299

This initiative will support multi-level and/or multi-domain intervention research to reduce disparities in liver diseases and liver cancer among populations who experien…

National Institutes of Health United States

Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)

PAR-24-311

The purpose of this Notice of Funding Opportunity (NOFO) is to invite research grant applications (R01) for the development and use of current and emerging molecular imag…

National Institutes of Health United States

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

PA-25-253

This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of ca…

National Institutes of Health United States

Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)

PAR-25-324

The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providin…

National Institutes of Health United States

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

PAR-25-444

This Notice of Funding Opportunity (NOFO) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-Designated Cancer Centers. CCSGs support three …

National Institutes of Health United States

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

PAR-28-022

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Res…

National Institutes of Health United States

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

PAR-28-014

This Notice of Funding Opportunity (NOFO) invites applications that investigate the etiology of sporadic non-hereditary early-onset cancers (EOCs: ages 18 to 49 years) an…

Topic pages match calls by keywords in their official titles, descriptions and keywords (cancer, oncolog, tumour, tumor, carcinoma, leukemia, leukaemia, lymphoma…). A match does not decide eligibility.